Blueprint Medicines Corp (56)

Browse by Contract Category

Contracts

First Amendment to Amended and Restated Employment Agreement, dated September 23, 2022, by and between the Registrant and Philina Lee (Filed With SEC on September 23, 2022)
Purchase and Sale Agreement, dated as of June 30, 2022, by and between the Registrant and Royalty Pharma Investments 2019 ICAV (Filed With SEC on August 2, 2022)
Blueprint Medicines Corporation Amended and Restated 2020 Inducement Plan (Filed With SEC on June 27, 2022)
Tenth Amendment to Collaboration and License Agreement, effective August 4, 2016, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant (Filed With SEC on May 3, 2022)
Third Amendment to Lease Agreement, dated December 15, 2021, by and between Blueprint Medicines Corporation and BRE-BMR 38 SIDNEY LLC (Filed With SEC on February 17, 2022)
Agreement and Plan of Merger by and among the Company, Pavonis Merger Subsidiary, Inc., Lengo Therapeutics, Inc. and Fortis Advisors, LLC, dated November 27, 2021 (Filed With SEC on December 30, 2021)
License Agreement, effective October 15, 2019, by and between Blueprint Medicines Corporation and Clementia Pharmaceuticals, Inc (Filed With SEC on November 5, 2019)
First Amendment to Amended and Restated Employment Agreement, dated September 23, 2022, by and between the Registrant and Kathryn Haviland (Filed With SEC on September 23, 2022)
Second Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Ariel Hurley (Filed With SEC on September 23, 2022)
Third Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Debra Durso-Bumpus (Filed With SEC on September 23, 2022)
Second Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Percy H. Carter (Filed With SEC on September 23, 2022)
Second Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Christopher Murray (Filed With SEC on September 23, 2022)
Second Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Lemuel Becker Hewes (Filed With SEC on September 23, 2022)
Second Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Tracey L. McCain (Filed With SEC on September 23, 2022)
Second Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Fouad Namouni (Filed With SEC on September 23, 2022)
First Amendment to Amended and Restated Employment Agreement, dated September 23, 2022, by and between the Registrant and Christina Rossi (Filed With SEC on September 23, 2022)
Third Amendment to Employment Agreement, dated September 23, 2022, by and between the Registrant and Michael Landsittel (Filed With SEC on September 23, 2022)
Purchase and Sale Agreement, dated as of June 30, 2022, by and among the Registrant Garnich Adjacent Investments S.a.r.l. the various other purchasers from time to time party... (Filed With SEC on August 2, 2022)
Collaboration and License Agreement dated as of February 26, 2022 by and between Oncopia Therapeutics, Inc., d/b/a Proteovant Therapeutics, Inc. and the Registrant (Filed With SEC on May 3, 2022)
Sales Agreement, dated as of February 17, 2022, by and between Blueprint Medicines Corporation and Cowen and Company, LLC (Filed With SEC on February 17, 2022)
Amended and Restated Employment Agreement, dated January 19, 2022 and effective as of April 4, 2022, by and between the Registrant and Philina Lee (Filed With SEC on January 20, 2022)
Amended and Restated Employment Agreement, dated January 4, 2022 and effective as of April 4, 2022, by and between the Registrant and Christina Rossi (Filed With SEC on January 5, 2022)
Amended and Restated Employment Agreement, dated January 4, 2022 and effective as of April 4, 2022, by and between the Registrant and Kathryn Haviland (Filed With SEC on January 5, 2022)
Amended and Restated Employment Agreement, dated January 4, 2022 and effective as of April 4, 2022, by and between the Registrant and Jeffrey W. Albers (Filed With SEC on January 5, 2022)
First Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Christopher Murray (Filed With SEC on December 23, 2021)
First Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Ariel Hurley (Filed With SEC on December 23, 2021)
Second Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Debra Durso-Bumpus (Filed With SEC on December 23, 2021)
First Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Percy H. Carter (Filed With SEC on December 23, 2021)
First Amendment to Amended and Restated Employment Agreement, dated December 22, 2021, by and between the Registrant and Becker Hewes (Filed With SEC on December 23, 2021)
First Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Christina Rossi (Filed With SEC on December 23, 2021)
First Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Tracey L. McCain (Filed With SEC on December 23, 2021)
Second Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Kathryn Haviland (Filed With SEC on December 23, 2021)
First Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Fouad Namouni (Filed With SEC on December 23, 2021)
Second Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Michael Landsittel (Filed With SEC on December 23, 2021)
First Amendment to Employment Agreement, dated December 22, 2021, by and between the Registrant and Jeffrey W. Albers (Filed With SEC on December 23, 2021)
Employment Agreement, effective as of May 19, 2021, by and between the Registrant and Percy Carter (Filed With SEC on July 29, 2021)
Second Amendment to Lease Agreement, dated April 6, 2021, by and between Blueprint Medicines Corporation and BRE-BMR 38 SIDNEY LLC (Filed With SEC on April 29, 2021)
Ninth Amendment to Collaboration and License Agreement, effective January 8, 2021, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant (Filed With SEC on February 17, 2021)
Amended and Restated Employment Agreement, dated January 11, 2021, by and between the Registrant and Becker Hewes, M.D (Filed With SEC on January 11, 2021)
First Amendment to Employment Agreement, dated January 11, 2021, by and between Blueprint Medicines Corporation and Anthony L. Boral, M.D., Ph.D (Filed With SEC on January 11, 2021)
Employment Agreement, effective September 1, 2020, by and between Blueprint Medicines Corporation and Fouad Namouni, M.D (Filed With SEC on September 1, 2020)
Sales Agreement, dated as of July 30, 2020, by and between Blueprint Medicines Corporation and Cowen and Company, LLC (Filed With SEC on July 31, 2020)
Eighth Amendment to Collaboration and License Agreement, effective April 30, 2020, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation (Filed With SEC on May 6, 2020)
Employment Agreement, dated November 22, 2017, by and between the Registrant and Debra Durso-Bumpus, as amended by the First Amendment to Employment Agreement, dated February 10,... (Filed With SEC on February 13, 2020)
2015 Employee Stock Purchase Plan (Filed With SEC on February 13, 2020)
2015 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on February 13, 2020)
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on February 13, 2020)
Underwriting Agreement, dated as of January 22, 2020, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on January 23, 2020)
Seventh Amendment to Collaboration and License Agreement, effective December 17, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines... (Filed With SEC on December 20, 2019)
Sixth Amendment to Collaboration and License Agreement, effective November 1, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines... (Filed With SEC on November 5, 2019)
Fifth Amendment to Collaboration and License Agreement, effective June 28, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation (Filed With SEC on July 3, 2019)
Underwriting Agreement, dated as of March 28, 2019, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on March 29, 2019)
Employment Agreement, effective March 6, 2019, by and between Blueprint Medicines Corporation and Ariel Hurley (Filed With SEC on March 8, 2019)
Fourth Amendment to Collaboration and License Agreement, effective February 25, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant (Filed With SEC on February 26, 2019)
First Amendment to Employment Agreement, dated January 30, 2019, by and between the Registrant and Kathryn Haviland (Filed With SEC on February 5, 2019)
First Amendment to Employment Agreement, dated January 30, 2019, by and between the Registrant and Michael Landsittel (Filed With SEC on February 5, 2019)